New

Centralizované burzy

Decentralizované burzy

Produkty

Amgen stock price
AMGN
#62

1.16%

Amgen Info

Tržní kapitalizace: 3,86T Kč
1.16%
Denní objem: 12,51B Kč

Webová stránka

www.amgen.com

Druh aktiva

Akcie

Zaměstnanci

28000

Založeno

Apr 8, 1980

Primární burza

Nasdaq

Odvětví

Biological Products, (No Diagnostic Substances)

Číslo CIK

0000318154

Tokenizovaná data o akciích

Průměrná tokenizovaná cena: 7,16K Kč
Cenový rozdíl: +3,98 Kč(-0.06%)
Tokenizovaná tržní kapitalizace: 455,62K Kč
0.37%
Tokenizovaný objem (24 hodin): 17,21M Kč
4.11%

Emitenti

Ondo Assets

Kontrakty

Průzkumníci

etherscan.io

Směnárna AMGN na USD

AMGN

CZK

Cenový výkon

Nízké
7,11K Kč

Vysoké
7,23K Kč

Načítání dat

Čekejte prosím, načítáme data grafu

Amgen komunita

About Amgen

What is Amgen?

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.

Amgen Kurz a Live Cena

The current price of Amgen in the market is 7 164,04 Kč, with a 24-hour trading volume of 12,51B Kč. The asset's market cap is 3,86T Kč, after moving -1.17% in the last day.

Tokenized Amgen is trading at 7 160,05 Kč, with a tokenized market cap of 455,62K Kč and a 24-hour trading volume of 17,21M Kč. The tokenized asset has moved -0.38% in the past 24 hours.

Amgen stock priceAMGN#62